SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges

SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges

Autoimmune diseases (AIDs) are conditions where the immune system mistakenly attacks self-antigens, leading to tissue and organ damage. The exact mechanisms underlying AIDs pathogenesis remain unclear, and effective treatments are currently limited, posing significant therapeutic challenges. Recent...

Full description

Saved in:
Bibliographic Details
Main Authors: Taimin Luo, Liaoyun Zhang, Kun Tu, Gen Li, Hao Su, Guanli Gong, Yilan Huang, Min Li, Xuping Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
SGLT2 inhibitors
autoimmune diseases
T cells
metabolic reprogramming
inflammatory response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589341/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items